Contraception encompasses methods and devices used to prevent pregnancy by interfering with the normal process of ovulation, fertilization, and implantation. Pharmacologically, contraceptive agents primarily utilize synthetic sex hormones—estrogens and progestins—to manipulate the hypothalamic-pituitary-ovarian axis. By maintaining steady circulating levels of these exogenous hormones, negative feedback is exerted on the hypothalamus and anterior pituitary gland. This suppresses the mid-cycle surge of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby preventing follicular maturation and ovulation.
Hormonal contraceptives are classified based on their hormone composition and route of administration.
Combined Oral Contraceptives (COCs) are typically taken daily in 21-day or 28-day cycles. The 28-day packs include inactive reminder pills to maintain daily user habits. Injectable contraceptives, such as Depot Medroxyprogesterone Acetate (DMPA), are administered intramuscularly or subcutaneously every two to three months. While COCs require strict daily compliance to maintain efficacy, injectables offer discreet, longer-lasting systemic coverage but can cause a delayed return to fertility after discontinuation.
Progestin-Only Pills (POPs), often called the 'mini-pill,' must be taken at the exact same time every day due to their short half-life; a delay of more than three hours can compromise contraceptive efficacy. Emergency Contraceptive Pills (ECPs), containing high-dose progestin (levonorgestrel) or selective progesterone receptor modulators (ulipristal acetate), are used to prevent pregnancy after unprotected intercourse or contraceptive failure. ECPs work primarily by delaying or inhibiting ovulation; they do not disrupt an established implantation.
Long-Acting Reversible Contraception (LARC) includes intrauterine devices (IUDs)—both hormonal and copper-bearing—and subdermal implants. LARCs offer high efficacy rates because they require little to no ongoing user action once inserted by a trained clinician. Copper IUDs release copper ions that create a spermicidal and hostile intrauterine inflammatory environment. Barrier methods, such as male and female condoms, diaphragms, and cervical caps, provide a physical block against sperm and offer the added advantage of reducing sexually transmitted infection (STI) transmission.
Contraceptive agents can induce various side effects related to their hormonal components. Estrogen excess may cause breast tenderness, fluid retention, nausea, and headaches. Progestin excess can result in weight gain, acne, mood changes, and fatigue. A critical adverse reaction associated with combined hormonal contraceptives is venous thromboembolism (VTE), linked to estrogen-induced changes in hepatic clotting factor synthesis.
Safety screening is essential before initiating hormonal contraception. Absolute contraindications for combined hormonal contraceptives include a history of deep vein thrombosis, ischemic heart disease, known or suspected breast cancer, severe liver disease, and migraines with aura in women over age 35. Furthermore, liver enzyme-inducing drugs, such as certain anticonvulsants (phenytoin, carbamazepine) and rifampicin, accelerate the hepatic metabolism of contraceptive hormones, significantly reducing their plasma concentrations and contraceptive efficacy.
Nurses play a pivotal role in family planning services across Nigerian healthcare facilities. Comprehensive nursing care involves taking a detailed medical, obstetric, and social history to identify contraindications. Patient education must address the correct usage of the chosen method, expected side effects, management of missed doses, and the recognition of warning signs. Counseling should be culturally sensitive, client-centered, and address common local myths or misconceptions surrounding fertility and modern contraceptives.